Mizuho, through its acquisitions of Capstone Partners and Greenhill & Co., added breadth to its alternative investment market offerings.
Fundraising to the next level
The primary capital advisory business works on behalf of GPs, to raise funds through its vast network of LPs by positioning the fund strategy and providing transparency. Our PCA professionals are able to diversify sources of funding for GPs around the world.
- Leading global agent with stable team
- Highly selective client focus
- Dynamic, process-driven approach
- Proven fundraising success
Notable Transactions
- Placement agent for Align Capital III, a $620 million fund focused on lower middle market buyout investments in North America
- Placement agent for Amulet Capital III, a $1.2 billion fund focused on value-oriented investments in healthcare services
- Placement agent for Arctos Sports Partners I, a $2.1 billion fund focused on minority positions in pro sports franchises
- Placement agent for Atlas Capital Resources IV, a $3.1 billion fund focused on control investments in distressed opportunities
- Placement agent for RiverGlade Capital II, a $453 million fund focused on lower mid-market healthcare investments
Product Expertise
Providing creative capital solutions to GPs and LPs
Our secondary capital advisory experts work together with GPs and LPs to provide liquidity sources to those looking to monetize illiquid assets. Our professionals have worked with many of the world’s largest, most sophisticated institutional investors on leveraging the secondary market through structures such as sponsor-led transactions, fund liquidity solutions, secondary directs, management company monetization, fund valuation and sales.
Notable Transactions
- Adviser to Shin Kong Life Insurance with respect to the divestment of buyout, growth and infrastructure LP fund interests
- Adviser to Crescent Capital Partners, an Australian private equity firm, on the establishment of a single-asset continuation vehicle for Healthcare Australia, a leading workforce solutions and direct case healthcare services provider
- Adviser to a leading Japanese financing institution on the $3.4 billion sale of a portfolio of buyout and infrastructure fund and co-investment LP interests